JP2016513472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513472A5 JP2016513472A5 JP2016502468A JP2016502468A JP2016513472A5 JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5 JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- cell population
- cells
- pge2
- contacted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792818P | 2013-03-15 | 2013-03-15 | |
| US61/792,818 | 2013-03-15 | ||
| PCT/US2014/027521 WO2014152603A1 (en) | 2013-03-15 | 2014-03-14 | Stem cell culture media and methods of enhancing cell survival |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000736A Division JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016513472A JP2016513472A (ja) | 2016-05-16 |
| JP2016513472A5 true JP2016513472A5 (enExample) | 2017-04-20 |
Family
ID=51581254
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502468A Pending JP2016513472A (ja) | 2013-03-15 | 2014-03-14 | 幹細胞培養培地及び細胞生存を増強する方法 |
| JP2020000736A Pending JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000736A Pending JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9943545B2 (enExample) |
| EP (1) | EP2970894A4 (enExample) |
| JP (2) | JP2016513472A (enExample) |
| CN (1) | CN105358679A (enExample) |
| AU (1) | AU2014239290B2 (enExample) |
| CA (1) | CA2906641C (enExample) |
| WO (1) | WO2014152603A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3269802B1 (en) * | 2011-09-30 | 2019-10-23 | Bluebird Bio, Inc. | Compounds for improved viral transduction |
| IL305070B2 (en) | 2014-12-30 | 2025-11-01 | Cell Cure Neurosciences Ltd | Rpe cell populations and methods of generating same |
| WO2016123100A1 (en) | 2015-01-26 | 2016-08-04 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016120891A1 (en) * | 2015-01-30 | 2016-08-04 | Coral Drugs Pvt. Ltd. | Novel process for preparation of glucocorticoid steroids |
| KR20180033537A (ko) | 2015-07-21 | 2018-04-03 | 더 칠드런스 메디칼 센터 코포레이션 | Pd-l1 발현 조혈 줄기 세포 및 용도 |
| CN108368520B (zh) | 2015-11-04 | 2023-01-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
| WO2017078807A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| CN105713880A (zh) * | 2016-04-20 | 2016-06-29 | 广东艾时代生物科技有限责任公司 | 一种造血干细胞体外扩增培养的无血清培养基及其应用 |
| CN105749252B (zh) * | 2016-04-29 | 2025-11-14 | 南方医科大学 | Il-9作为治疗血小板缺少症的药物的应用 |
| US10426796B2 (en) | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| CN106434549A (zh) * | 2016-12-20 | 2017-02-22 | 江西宜信堂医疗科技有限公司 | 一种无血清干细胞培养基及其制备方法 |
| KR102018609B1 (ko) * | 2017-04-26 | 2019-09-06 | 이장호 | 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물 |
| US11879137B2 (en) | 2017-09-22 | 2024-01-23 | The Children's Medical Center Corporation | Treatment of type 1 diabetes and autoimmune diseases or disorders |
| CN111741735A (zh) * | 2017-12-29 | 2020-10-02 | 细胞治疗神经科学有限公司 | 视网膜色素上皮细胞组合物 |
| JP7036670B2 (ja) * | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
| CN110894490A (zh) * | 2018-09-13 | 2020-03-20 | 李陶 | 一种脐带造血干细胞体外扩增培养体系和脐带造血干细胞体外扩增方法 |
| AU2019368313A1 (en) * | 2018-10-24 | 2021-05-20 | Hebecell Corporation | Methods and systems for manufacturing hematopoietic lineage cells |
| US20220220561A1 (en) * | 2019-03-18 | 2022-07-14 | Advanced ReGen Medical Technologies, LLC | Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment |
| CN110317782B (zh) * | 2019-07-18 | 2023-06-13 | 天津瑞博斯生物技术有限公司 | 提高间充质干细胞复苏后存活的方法和所用的冻存液 |
| CN112779209B (zh) * | 2019-11-08 | 2023-01-24 | 合肥中科普瑞昇生物医药科技有限公司 | 原代乳腺上皮细胞培养基、培养方法及其应用 |
| CN110923194B (zh) * | 2019-12-23 | 2021-08-13 | 广东依浦赛生物科技有限公司 | 一种原代细胞培养的方法 |
| TWI888659B (zh) * | 2021-10-13 | 2025-07-01 | 芯芮生技開發股份有限公司 | 幹細胞條件培養基於製備抑制癌症組成物的用途 |
| CN116889226A (zh) * | 2022-04-02 | 2023-10-17 | 杭州启函生物科技有限公司 | Nk细胞冻存液 |
| IL317136A (en) * | 2022-06-03 | 2025-01-01 | Bluerock Therapeutics Lp | Cell delivery device and methods of use thereof |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5405772A (en) | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| JP2000507812A (ja) * | 1996-03-12 | 2000-06-27 | ライフ テクノロジーズ，インコーポレイテッド | 造血細胞培養栄養補充成分 |
| PL335227A1 (en) * | 1997-02-20 | 2000-04-10 | Dsm Nv | Industrial-scale production of valuable compounds by fermentation in a chemically defined medium |
| US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| JP2000201672A (ja) * | 1999-01-11 | 2000-07-25 | Asahi Medical Co Ltd | 有核細胞の凍結保存用組成物 |
| EP1219600A4 (en) | 1999-08-13 | 2004-11-03 | Taisho Pharmaceutical Co Ltd | PROSTAGLANDIN DERIVATIVES |
| PT1132086E (pt) | 2000-01-31 | 2006-09-29 | Pfizer Prod Inc | Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US7968329B2 (en) * | 2000-10-06 | 2011-06-28 | Michael Dancu | Method of conditioning a hybrid synthetic tubular structure to yield a functional human hybrid coronary bypass graft |
| JP2003225084A (ja) | 2000-12-28 | 2003-08-12 | Japan Science & Technology Corp | 凍結細胞保存剤 |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| IL162648A0 (en) | 2001-12-21 | 2005-11-20 | Mount Sinai Hospital Corp | Cellular compositions and methods of making and using them |
| US7176022B2 (en) * | 2002-12-20 | 2007-02-13 | Cell Genesys, Inc. | Directly injectable formulations which provide enhanced cryoprotection of cell products |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| JP2008518013A (ja) | 2004-10-26 | 2008-05-29 | アラーガン、インコーポレイテッド | プロスタグランジンｅｐ４アゴニストによる処置方法およびデリバリー方法 |
| US20060193839A1 (en) * | 2005-02-28 | 2006-08-31 | Donnie Rudd | Method of providing readily available cellular material derived from peripheral blood, and a composition thereof |
| MX2007015201A (es) * | 2005-06-02 | 2008-03-14 | Stemcyte Inc | Composiciones y metodos de uso de sangre de cordon umbilical agotada de plasma, no agotada de globulos rojos. |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| MX373998B (es) * | 2006-03-24 | 2020-07-22 | Childrens Medical Center | Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc. |
| EP2069479A1 (en) * | 2006-09-18 | 2009-06-17 | Medizinische Universität Graz | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| EP3824885A1 (en) | 2006-10-20 | 2021-05-26 | Children's Medical Center Corporation | Method to enhance tissue regeneration |
| EP2094839B1 (en) | 2006-12-08 | 2020-02-05 | University of Rochester | Expansion of hematopoietic stem cells |
| DK2330889T3 (en) | 2008-08-20 | 2017-01-30 | Anthrogenesis Corp | Improved cell composition and process for making the same |
| EP3031907B1 (en) | 2008-11-06 | 2021-01-06 | Indiana University Research and Technology Corporation | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| EP3533445A1 (en) | 2009-03-19 | 2019-09-04 | Fate Therapeutics, Inc. | Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| SG175880A1 (en) | 2009-05-20 | 2011-12-29 | Cardio3 Biosciences Sa | Parmaceutical composition for the treatment of heart diseases. |
| ES2727787T3 (es) | 2009-11-15 | 2019-10-18 | Univ Indiana Res & Tech Corp | Métodos para mejorar el suministro y el injerto de células madre incluida la identificación de receptores específicos de prostaglandina E2 |
| JP5773347B2 (ja) * | 2009-11-27 | 2015-09-02 | 国立大学法人 千葉大学 | 血液細胞の凍結保存剤 |
| EP2603227B1 (en) | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| TWI535377B (zh) * | 2011-09-01 | 2016-06-01 | Storage, culture and application of umbilical cord tissue and its derived cells | |
| WO2013055476A1 (en) * | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
| PT2785834T (pt) | 2011-12-02 | 2020-11-13 | Fate Therapeutics Inc | Composição de células estaminais melhorada |
| US10111907B2 (en) | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
| WO2014150602A1 (en) | 2013-03-15 | 2014-09-25 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
-
2014
- 2014-03-13 US US14/209,131 patent/US9943545B2/en active Active
- 2014-03-14 CA CA2906641A patent/CA2906641C/en active Active
- 2014-03-14 JP JP2016502468A patent/JP2016513472A/ja active Pending
- 2014-03-14 AU AU2014239290A patent/AU2014239290B2/en not_active Ceased
- 2014-03-14 CN CN201480027789.8A patent/CN105358679A/zh active Pending
- 2014-03-14 EP EP14767366.9A patent/EP2970894A4/en not_active Withdrawn
- 2014-03-14 WO PCT/US2014/027521 patent/WO2014152603A1/en not_active Ceased
-
2018
- 2018-03-07 US US15/914,836 patent/US11135244B2/en not_active Expired - Fee Related
-
2020
- 2020-01-07 JP JP2020000736A patent/JP2020089373A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020089373A5 (enExample) | ||
| US11162075B2 (en) | Methods and compositions for inducing hematopoietic cell differentiation | |
| US10184112B2 (en) | Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof | |
| Zuk | Adipose‐derived stem cells in tissue regeneration: a review | |
| JP2022033900A (ja) | グルコース依存性ミトコンドリア呼吸及び二相インスリン分泌応答を示すヒト多能性幹細胞由来の機能的ベータ細胞の生成 | |
| KR101138091B1 (ko) | 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제 | |
| JP6636427B2 (ja) | 小分子を用いるヒト多能性幹細胞からの内分泌始原細胞の作製 | |
| Sart et al. | Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors | |
| JP6949336B2 (ja) | 人工多能性幹細胞由来腸管幹細胞の維持培養 | |
| JP2020089373A (ja) | 幹細胞培養培地及び細胞生存を増強する方法 | |
| WO2018143258A1 (ja) | 多分化能性幹細胞増殖促進剤 | |
| US20230340415A1 (en) | Methods and compositions for generating hematopoietic cells | |
| CN108060126B (zh) | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 | |
| Tarle et al. | Development of a serum‐free system to expand dental‐derived stem cells: PDLSCs and SHEDs | |
| JP6643993B2 (ja) | 膵島様細胞構造体及びそれを調製する方法 | |
| Kuci et al. | Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells | |
| JP2019134682A (ja) | 肝幹細胞様細胞の調製方法 | |
| JP2024543217A5 (enExample) | ||
| CN111607556B (zh) | 一种培养扩增人肝祖细胞的培养基及其应用 | |
| US20230002729A1 (en) | Cell culture medium composition | |
| EP3792345A1 (en) | Method for promoting differentiation of pluripotent stem cells | |
| WO2024113358A1 (en) | Methods and compositions for differentiation of pluripotent stem cells and derived natural killer cells | |
| CN115427549A (zh) | 干细胞用培养基及干细胞的培养方法 | |
| Mohammadali et al. | Combined mild hypoxia and bone marrow mesenchymal stem cells improve expansion and HOXB4 gene expression of human cord blood CD34+ stem cells | |
| US20240352419A1 (en) | Methods and compositions for differentiation of pluripotent stem cells and derived hematopoietic lineage cells |